After sitting and learning behind Quinn Ewers for the past couple of seasons, head coach Steve Sarkisian has already named the nephew of Peyton and Eli Manning the starter, which some fans may ...

However, with Ewers declaring for the 2025 NFL Draft, Manning will become QB1 at Texas in the 2025 season. As a former five-star recruit and the nephew of Eli and Peyton Manning, all eyes will be ...

Nearly a year after his speech was disrupted by an angry mob of student protesters, Kyle Rittenhouse will return to the University of Memphis on Wednesday evening to talk about the Second ...

Eli Lilly plans to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the U.S. The drugmaker, which had committed to $23 billion in domestic investments from 2020 ...

Drugmaker Eli Lilly plans to invest up to $27 billion to build four new pharmaceutical manufacturing sites in the U.S., the company announced Wednesday, a move that comes as President Trump is ...

Last year, Kyle Richards admitted that seeing paparazzi photos of Mauricio Umansky kissing another woman in an airport was "a little jarring," but the above preview of The Real Housewives of ...

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States ...

Investing.com -- On Wednesday, Eli Lilly (NYSE:LLY) announced plans to invest an additional $27 billion in U.S. pharmaceutical manufacturing, bringing its total domestic capital expansion ...

Feb. 26 (UPI) --Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in ...

All told, Eli Lilly has tallied up about $23 billion in U.S. manufacturing commitments in recent years. The new pledge represents about $27 billion in additional planned spending. Related ...

Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a deal worth up to $50 million in biobucks. Organovo’s stock ...